Skip to content
POM-VPS Prescription Required

Panacur Equine 222 mg/g Granules

Active ingredient: Fenbendazole

Form

Powder

Species

Horses

Manufacturer

Intervet International B.V.

VMD MA No.

06376/4092

What it's used for

The veterinary medicinal product effectively treats and controls the following roundworm infections: Large strongyles (adults and migrating larval stages o...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Fenbendazole

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Panacur Equine 222 mg/g Granules — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

The veterinary medicinal product effectively treats and controls the following
roundworm infections:
Large strongyles (adults and migrating larval stages of S. vulgaris; adults and tissue
larval stages of S. edentatus).
Benzimidazole susceptible adult and immature small strongyles (cyathostomes)
including encysted mucosal 3rd and 4th stage larvae and it is also effective against
inhibited 3rd stage larvae (encysted) in the mucosa.
Adult and immature Oxyuris spp., StrongyloidesParascaris equorum.
This veterinary medicinal product has an ovicidal effect on nematode eggs.
To ensure a correct dosage, bodyweight should be determined as accurately as
possible.
The use of suitably calibrated measuring equipment is recommended. Accuracy of
the dosing device should be checked.
The veterinary medicinal product should be sprinkled onto concentrate or grain feed
and the full dosage given as one administration. It is not necessary to withhold feed
before or after treatment.
Routine treatment: Administer orally 5 g of the veterinary medicinal product per
150 kg bodyweight.
(= 7.5mg fenbendazole/kg bodyweight)
Practical dosage recommendations:
Up to 150 kg 5 g
151 to 300 kg 10 g
301 to 450 kg 15 g
451 to 600 kg 20 g
601 to 750 kg 25 g
751 to 900 kg 30 g
Each sachet contains 10.2 g granules and can be used as follows:
Foals and ponies up to 300 kg bodyweight 1 sachet
Thoroughbreds and other breeds of horses
up to 600 kg bodyweight 2 sachets
Heavy hunters, heavy draft horses 3 sachets
Donkeys 1 sachet
Increased dosing for specific infections
Five-day course:
For the treatment and control of migrating larval stages of large strongyles and
encysted mucosal 3
rd
and 4
th
stage larvae and inhibited 3
rd
stage small strongyle
larvae (encysted) in the mucosa, administer 5 g of the veterinary medicinal product
per 150 kg bodyweight daily for 5 consecutive days.
(= 7.5 mg fenbendazole/kg bodyweight daily for 5 days)
Single dose treatments:
For the treatment and control of encysted mucosal stages of small strongyles,
administer 20 g of the veterinary medicinal product per 150 kg bodyweight.
(= 30 mg fenbendazole/kg bodyweight)
For the treatment and control of migrating stages of large strongyles, administer 40 g
of the veterinary medicinal product per 150 kg bodyweight.
AN: 01735/2025 & 01736/2025
(= 60 mg fenbendazole/kg bodyweight)
Diarrhoea caused by in two- to three-week-old suckling foals
should be treated with Panacur 10% Suspension at a dose rate of 25 ml per 50 kg
bodyweight.
(= 50 mg fenbendazole/kg bodyweight)
Recommended dosing programme:
Inappropriate use of anthelmintics may increase resistance selection pressure and
lead to reduced efficacy. The decision to use the product should be based on
professional advice and take into account current best practice recommendations for
parasite control.
Seek veterinary advice for appropriate monitoring, stock management and dosing
programmes to allow optimum endoparasite control.
None known.
AN: 01735/2025 & 01736/2025
Horses and other equids:
None known.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
Care should be taken to avoid the following practices because they increase the risk
of development of resistance and could ultimately result in ineffective therapy:
•
extended period of time.
•
misadministration of the veterinary medicinal product, or lack of calibration of the
dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of
the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic
belonging to another pharmacological class and having a different mode of action
should be used.
Resistance to fenbendazole has been reported in cyathostomes in horses. Therefore,
the use of this veterinary medicinal product should be based on local (regional, farm)
epidemiological information about susceptibility of nematodes and recommendations
on how to limit further selection for resistance to anthelmintics.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Direct contact with the skin should be kept to a minimum. Avoid inhalation of granule
dust. Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
None known.
This veterinary medicinal product does not require any special storage conditions.
Not to be used in horses intended for human consumption.
Treated horses may never be slaughtered for human consumption.
The horse must have been declared as not intended for human consumption under
national horse passport legislation.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.